Renovaro Biosciences Inc (RENB)

Precedente Chiudi:

$1.16

Aprire:

$1.16

Volume 24 ore:

258.48K

Capitalizzazione di mercato:

$149.42M

Reddito:

-

Utile/perdita netta:

$-41.23M

Rapporto P/E:

-1.4648

EPS:

-0.71

Flusso di cassa netto:

$-11.54M

1 W Prestazione:

-30.20%

1M Prestazione:

-55.93%

6M Prestazione:

-65.68%

1 anno Prestazione:

+0.00%

Intervallo 1D:

$1.01

$1.1694

Portata 52W:

$1.01

$5.25

Renovaro Biosciences Inc Stock (RENB) Company Profile

Nome

Renovaro Biosciences Inc

Settore

Healthcare (1211)

Industria

Biotechnology (696)

Telefono

305 918 1980

Indirizzo

Century City Medical Plaza, Suite 906 2080 Century Park East, Los Angeles

Dipendente

22

Cinguettio

Prossima data di guadagno

2024-05-13

Ultimi documenti SEC

RENB's Discussions on Twitter

Renovaro Biosciences Inc Borsa (RENB) Ultime notizie

Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

GlobeNewswire Inc.

Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care

GlobeNewswire Inc.

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

GlobeNewswire Inc.

Statement of Renovaro Inc

GlobeNewswire Inc.

Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Renovaro Biosciences Inc Azioni (RENB) Dati Finanziari

Renovaro Biosciences Inc (RENB) Reddito netto 2024

Renovaro Biosciences Inc (RENB) Flusso di cassa 2024

Renovaro Biosciences Inc (RENB) Utile per azione 2024